Table 3.
Training effects on secondary outcomes post and 2-month follow-up
| Measure | Memory training
|
Speed of processing training
|
Wait-list control Mean (SD) |
||||
|---|---|---|---|---|---|---|---|
| Mean (SD) | Net effect size (p value)* | 95 % Confidence interval | Mean (SD) | Net effect size (p value)* | 95 % Confidence interval | ||
| FACT-COG | |||||||
| Post | 93.86 (15.54) | 0.59 (p = 0.036) | 0.05, 1.13 | 93.21 (15.50) | 0.55 (p = 0.042) | 0.01, 1.08 | 84.82 (15.80) |
| 2-month | 98.17 (15.34) | 0.65 (p = 0.021) | 0.11, 1.19 | 94.98 (15.29) | 0.44 | −0.09, 0.97 | 88.32 (15.59) |
| Squire | |||||||
| Post | 83.58 (15.59) | 0.71 (p = 0.012) | 0.17, 1.25 | 79.51 (15.54) | 0.44 | −0.09, 0.98 | 72.69 (15.83) |
| 2-month | 86.47 (13.54) | 0.84 (p = 0.003) | 0.30, 1.39 | 81.95 (13.48) | 0.51(p = 0.065) | −0.02, 1.04 | 75.15 (13.74) |
| CES-D | |||||||
| Post | 9.69 (7.47) | −0.29 | −0.25, 0.84 | 10.39 (8.56) | −0.60 (p = 0.031) | 0.06, 1.13 | 15.00 (12.37) |
| 2-month | 7.88 (5.40) | −0.46 | 1.01,−0.08 | 7.85 (7.16) | −0.86 (p = 0.002) | 1.39, 0.33 | 13.79 (11.60) |
| STAI-S | |||||||
| Post | 31.96 (8.10) | −0.40 | −0.14, 0.94 | 33.78 (8.32) | −0.52 (p = 0.059) | −0.01, 1.05 | 37.07 (11.09) |
| 2-month | 30.15 (6.97) | −0.68 (p = 0.017) | 1.22, 0.13 | 32.15 (7.46) | −0.76 (p = 0.006) | 1.30, 0.23 | 36.97 (11.01) |
| FACT-F | |||||||
| Post | 40.20 (9.22) | 0.46 | −0.17, 0.91 | 39.26 (8.90) | 0.74 (p = 0.008) | 0.21, 1.26 | 35.07 (12.07) |
| 2-month | 40.06 (9.93) | 0.37 | −0.17, 0.91 | 39.56 (8.96) | 0.78 (p = 0.005) | 0.25, 1.32 | 35.55 (12.56) |
| QOL-CS | |||||||
| Post | 6.54 (1.29) | −0.23 | −0.78, 0.32 | 6.55 (0.61) | −0.23 | −0.76, 0.30 | 6.73 (0.59) |
| 2-month | 6.02 (1.32) | 0.15 | −0.40, 0.70 | 6.69 (0.63) | 0.17 | −0.37, 0.70 | 6.88 (1.12) |
| QOL-CV | |||||||
| Post | 22.06 (3.44) | −0.06 | −0.61, 0.48 | 22.98 (2.08) | 0.13 | −0.40, 0.66 | 23.38 (2.24) |
| 2-month | 22.15 (4.45) | −0.02 | −0.56, 0.52 | 22.71 (2.08) | 0.37 | −0.17, 0.90 | 22.58 (2.24) |
| SF-36-physical | |||||||
| Post | 45.71 (5.98) | 0.08 | −0.46, 0.62 | 44.69 (4.40) | −0.07 | −0.60, 0.46 | 43.18 (4.72) |
| 2-month | 45.03 (6.17) | 0.11 | −0.43, 0.65 | 45.00 (4.48) | −0.28 | −0.81, 0.25 | 44.49 (4.81) |
| SF-36-Mental | |||||||
| Post | 45.33 (5.98) | 0.49 (p = 0.078) | −0.05, 1.04 | 47.33 (5.10) | 0.72 (p = 0.010) | 0.19, 1.26 | 48.09 (5.03) |
| 2-month | 44.91 (6.82) | 0.25 | −0.30, 0.79 | 43.67 (5.21) | 0.60 (p = 0.031) | 0.07, 1.13 | 45.11 (5.13) |
Post-test represents immediate post-intervention, 2-month represents 2-month follow-up
FACT-C Functional Assessment of Cancer Therapy-Cognitive, SSMQ Squire Subjective Memory Questionnaire, CES-D Center for Epidemiological Studies Scale, STAI-S State-Trait Anxiety Inventory-State Subscale, FACT-F Functional Assessment of Cancer Therapy-Fatigue, QOL-CS Quality of Life-Cancer Survivors, QOL-CV Quality of Life Index-Cancer Version, SF-36 Short-Form Health Survey
*
Only p values <0.08 reported